A 2026 network meta-analysis including over 13,000 participants found that tirzepatide intervention produced significantly better results than semaglutide across multiple measures, not just weight loss, but also improvements in blood sugar control and metabolic health markers
This update follows reports of adverse effects such as nausea, vomiting, and abdominal pain among users
In the present study, it was observed that the liraglutide/GLP-1R axis acts in chondrocytes and macrophages to decrease inflammation and catabolism in vitro, which was confirmed by pain alleviation in vivo in mouse OA inflammatory pain model
Why isn't the body shooting my leptin levels up to try to fight that GLP-1 signal, to say no, no, you're not taking in enough calories, we need more
Jagtap U, Bapat VA